ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements with these filters
Gujarat Kidney and Super Speciality Limited issued a corrigendum to its FY 2025-26 Annual Report. The update includes missing Secretarial Audit observations and management responses.
Gujarat Kidney and Super Speciality Limited has issued a notice for its 7th Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statements, director appointments, and related party transactions.
Gujarat Kidney and Super Speciality Limited filed a revised Annual Report for FY 2025-26. The document also includes the notice for its 7th Annual General Meeting.
Gujarat Kidney & Superspeciality Limited released its Annual Report for FY 2025-26. The report includes the notice for the 7th AGM scheduled for September 28, 2026.
Gujarat Kidney and Super Speciality Ltd appointed Mrs. (Dr) Disha Bharpoda as an Additional Non-Executive Independent Director. The Board also noted shareholder approval for IPO proceeds usage.
Gujarat Kidney And Superspeciality Limited shareholders approved a special resolution via postal ballot. The resolution authorizes variation in the objects/terms of utilization of IPO proceeds.
Gujarat Kidney and Super Speciality Ltd submitted its Regulation 32 statement regarding the utilization of IPO proceeds for the quarter ended June 30, 2026.
Gujarat Kidney and Super Speciality Ltd has appointed Mr. Paresh Dhoti as an Additional Non-Executive Independent Director for a five-year term, effective August 14, 2026.
Gujarat Kidney and Super Speciality Ltd reported revenue from operations of ₹34.3 Cr (+124.2% YoY) and net profit of ₹5.3 Cr (-1.9% YoY) for Q1 FY27.
Gujarat Kidney and Superspeciality Limited has scheduled a Board Meeting for August 14, 2026, to consider quarterly financial results.
Gujarat Kidney and Super Speciality Limited has issued a notice for a postal ballot meeting. Shareholders will vote on varying the objects of IPO proceeds.
Gujarat Kidney corrected an earlier filing, reclassifying the appointment of Mr. Paresh Dhoti as a Non-Executive Non-Independent Director due to pending IICA registration.
Gujarat Kidney and Super Speciality Ltd has filed its quarterly shareholding pattern. The report details holdings for promoters and public shareholders as of June 30, 2026.
Gujarat Kidney and Super Speciality appointed Mr. Paresh Mohanbhai Dhoti as Independent Director. He joins the board for a five-year term effective July 9, 2026.
Gujarat Kidney and Super Speciality acquires 51% of Dubai-based Blue Tree Clinics for ₹19.84 Crore. This expansion diversifies its medical services into the UAE market.
Gujarat Kidney and Super Speciality will acquire a 51% stake in UAE-based Blue Tree Clinics LLC for Rs 19.84 Crore. The acquisition expands operations into Dubai's medical services market.